You are here
Amniocentesis Needle Market for Fetal Blood Transfusion Procedures
[132 Pages Report] The amniocentesis needles market is expected to reach USD 172.8 million by 2022 from USD 146.4 million in 2016 at a CAGR of 2.8%.
The global amniocentesis needles market is segmented by type, procedure, end user, and regions. By type, the amniocentesis needle market is segmented into needles of length 100–150 mm, larger than 150 mm, and smaller than 100 mm. The 100–150 mm segment is estimated to account for the largest market share of the global amniocentesis needles market in 2017. Factors driving the growth of this segment include the widespread use of these needles on account of their optimal length and suitability of use for most patients.
By procedure, the market is classified into amniocentesis, amnioreduction, fetal blood transfusion, amnioinfusion, and cordocentesis. The amniocentesis segment is estimated to account for the largest share of the global amniocentesis needles market during the next five years. High reliability of the amniocentesis technique and the extensive use of this procedure to diagnose the abnormalities in the developing fetus are driving the growth of this market.
On the basis of end user, the amniocentesis needles market is segmented into hospitals, diagnostic centers, clinics, and other end users. The hospitals segment is estimated to account for the largest share of the global amniocentesis needles market during the forecast period. Growth in the number of hospitals coupled with better accessibility and availability of test results in hospitals are major factors driving the growth of this end-user segment.
Request Sample Report from Here – https://www.marketsandmarkets.com/requestsampleNew.asp?id=18541768
The global amniocentesis needles market is dominated by North America, followed by Europe. North America will continue to dominate the global amniocentesis needles market during the forecast period. Factors such as the rising government initiatives and increasing healthcare expenditure are driving the growth of the amniocentesis needles market in this region.
Browse Market Report with TOC Here – https://www.marketsandmarkets.com/Market-Reports/amniocentesis-needle-market-18541768.html
The availability of alternate methods is expected to limit market growth to a certain extent. Apart from amniocentesis, there are invasive as well as non-invasive techniques for screening and diagnosing fetal disorders or diseases. Invasive tests include chorionic villus sampling (CVS) and cordocentesis. CVS is preferred over amniocentesis as it is performed at an earlier stage of pregnancy and there is more time available to consider the results and take a final decision. However, there is a low probability of miscarriage associated with invasive tests, which may result in the reduced adoption of these tests. Non-invasive tests include blood tests, ultrasound measurements, and genomics-based non-invasive prenatal testing. These tests are preferred as there is no risk of miscarriage associated with them.
Major industry players acquired companies and business units from other companies to maintain and improve their position in the amniocentesis needles market. Medtronic (Ireland), BD (US), CooperSurgical (US), Integra LifeSciences (US), Smiths Medical (US), Medline (US), and Cook Medical (US) have been identified as the key players in this market. These companies have a broad product portfolio with comprehensive features. These leaders have products for all end users in this market, and have a strong geographical presence.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.